Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30

$8.09−0.04 (-0.49%)

Close on Nov 13, 2026Market cap $466.68MP/E –Yield –

Kamada EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Kamada's EV/EBITDA was 9.8× on Apr 30, 2026, against 49.8× a year earlier. Over the last 5 years it ranged from 5.6× to 51.4×, with a median of 10.1×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Apr 30, 2026	9.8×	+0.8
2025	Apr 30, 2025	9.0×	−2.4
2024	Apr 30, 2024	11.4×	−0.1
2023	Apr 28, 2023	11.5×	−38.3
2022	Apr 29, 2022	49.8×	+44.2
2021	Jul 30, 2021	5.6×	−2.1
2020	Dec 31, 2020	7.7×	−3.5
2019	Dec 31, 2019	11.2×	−6.2
2018	Dec 31, 2018	17.4×	–